Investor · Boston, MA

Jean-Pierre Sommadossi, Ph.D

Open Jean-Pierre in the network graph →

Filings

12

SEC Form D

Connections

51

co-filers

Capital

$128.3M

across filings

Active

Oct 2015

to Dec 2020

Most-connected co-filers (51)

Jere B. Clark · Scottsdale, AZ6 shared E Squared Asset Llc · NEW YORK, NY6 shared E Squared Asset Llc · NEW YORK, NY6 shared Eduard Ilyadzhanov · NEW YORK, NY6 shared Bruce Polsky · Boston, MA3 shared Sean M. Mcavoy · Burlingame, CA2 shared Glen Huber · Toronto, Ontario, Canada2 shared Andrea J. Corcoran · Boston, MA2 shared Todd Wilson · Vashon, WA2 shared Alan Friedman · Toronto, Ontario, Canada2 shared Jon Whalen · Vashon, WA2 shared Bruno Lucidi · Boston, MA2 shared Balan Ayyar · Santa Clara, CA2 shared Imran Aziz · Seattle, WA2 shared Kimble L. Jenkins · Irvine, CA2 shared Jason C. Rottenberg · Winter Park, FL2 shared Sonia K. Lutchmiah · Moka, O42 shared Stevan S. Armstrong · Brooklyn, NY2 shared Randolph Newcomer, Jr · HOUSTON, TX2 shared A. M. Finkelstein · Newark, NJ2 shared Michael Krestell · Nisku, Alberta, Canada2 shared Scott Rice · Houston, TX1 shared Ziad Khoury · Winter Park, FL1 shared Lucien A. Alziari · Newark, NJ1 shared

Recent filings (12)

Biothea Pharma, Inc.Aug 2021 · 12 co-filers$22.0M E Squared Capital Fund, LPDec 2020 · 4 co-filers Atea Pharmaceuticals, Inc.May 2020 · 22 co-filers$215.0M E Squared Capital Fund, LPDec 2019 · 4 co-filers E Squared Capital Fund, LPDec 2018 · 4 co-filers E Squared Capital Fund, LPDec 2017 · 4 co-filers E Squared Capital Fund, LPOct 2016 · 4 co-filers$500.0M Atea Pharmaceuticals, Inc.Sep 2016 · 16 co-filers$20.8M PharmaCan Capital Corp.May 2016 · 10 co-filers$10.8M PharmaCan Capital Corp.Oct 2015 · 18 co-filers$4.0M E Squared Capital Fund, LPOct 2015 · 4 co-filers Atea Pharmaceuticals, Inc.Dec 2013$12.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jean-Pierre in the interactive graph →